Literature DB >> 10892995

Characterization of immune response of young pigs to porcine circovirus type 2 infection.

R M Pogranichnyy1, K J Yoon, P A Harms, S L Swenson, J J Zimmerman, S D Sorden.   

Abstract

A longitudinal study was conducted to characterize the immune response of young swine to infection with porcine circovirus type 2 (PCV-2). Five 8-week-old cesarean-derived, colostrum-deprived pigs were inoculated intranasally and intramuscularly with a field isolate of PCV-2 at a concentration of 10(4) TCID50/mL. Along with monitoring for clinical signs and viremia, serum samples were collected from all pigs at day 0 and thereafter every 7 days postinoculation (PI) until the termination of the study on day 35 PI. No clinical signs were observed in any of the animals during the study period. In all pigs, PCV-2 was detected by polymerase chain reaction (PCR) in serum samples collected on days 7, 14, and 21 PI. Viral DNA and antigens were detected by in situ hybridization and immunohistochemistry in tonsil, spleen, medial iliac lymph nodes, and ileum collected from each pig at the end of the study. Collectively, naïve young swine were shown to be susceptible to PCV-2. Virus-specific antibody was detected by an indirect fluorescent antibody (IFA) assay on day 14 PI, but virus-neutralizing antibody was not detected until day 28 PI. As neutralizing antibodies developed, cross-reactivity with PCV type 1 (PCV-1) also developed on the IFA test. Western immunoblot analysis revealed three PCV-2 proteins with molecular masses of 28 kd, 28.5 kd, and 35 kd. The 35-kd protein was also demonstrated in PCV-1, suggesting that this protein induced the cross-reactivity between PCV types 1 and 2. Antibody to the 28-kd protein was detected on day 14 PI and later, indicating that this protein was the most immunogenic. Because of its immunogenicity and specificity to PCV-2, and 28-kd protein might provide the antigenic basis for the development of diagnostic tests for detection of PCV-2 antibody.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10892995     DOI: 10.1089/vim.2000.13.143

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  39 in total

1.  Cloned genomic DNA of type 2 porcine circovirus is infectious when injected directly into the liver and lymph nodes of pigs: characterization of clinical disease, virus distribution, and pathologic lesions.

Authors:  M Fenaux; P G Halbur; G Haqshenas; R Royer; P Thomas; P Nawagitgul; M Gill; T E Toth; X J Meng
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  Comparison of four commercial one-dose porcine circovirus type 2 (PCV2) vaccines administered to pigs challenged with PCV2 and porcine reproductive and respiratory syndrome virus at 17 weeks postvaccination to control porcine respiratory disease complex under Korean field conditions.

Authors:  Changhoon Park; Hwi Won Seo; Kiwon Han; Chanhee Chae
Journal:  Clin Vaccine Immunol       Date:  2014-01-08

3.  Immune responses of piglets immunized by a recombinant plasmid containing porcine circovirus type 2 and porcine interleukin-18 genes.

Authors:  Guang-Lei Chen; Peng-Fei Fu; Lin-Qing Wang; Xin-Sheng Li; Hong-Ying Chen
Journal:  Viral Immunol       Date:  2014-12       Impact factor: 2.257

4.  In silico analyses of antigenicity and surface structure variation of an emerging porcine circovirus genotype 2b mutant, prevalent in southern China from 2013 to 2015.

Authors:  Yang Zhan; Naidong Wang; Zhe Zhu; Zhanfeng Wang; Aibing Wang; Zhibang Deng; Yi Yang
Journal:  J Gen Virol       Date:  2016-01-11       Impact factor: 3.891

5.  Studies on porcine circovirus type 2 vaccination of 5-day-old piglets.

Authors:  K C O'Neill; H G Shen; K Lin; M Hemann; N M Beach; X J Meng; P G Halbur; T Opriessnig
Journal:  Clin Vaccine Immunol       Date:  2011-09-21

6.  Development of porcine circovirus 2 (PCV2) open reading frame 2 DNA vaccine with different adjuvants and comparison with commercial PCV2 subunit vaccine in an experimental challenge.

Authors:  Changhoon Park; Jiwoon Jeong; Kyuhyung Choi; Su-Jin Park; Ikjae Kang; Chanhee Chae
Journal:  Can J Vet Res       Date:  2017-07       Impact factor: 1.310

7.  Evaluation of the efficacy of a novel porcine circovirus type 2 synthetic peptide vaccine.

Authors:  Jiwoon Jeong; Changhoon Park; Seeun Kim; Su-Jin Park; Ikjae Kang; Kee Hwan Park; Chanhee Chae
Journal:  Can J Vet Res       Date:  2018-04       Impact factor: 1.310

8.  Immunogenicity and pathogenicity of chimeric infectious DNA clones of pathogenic porcine circovirus type 2 (PCV2) and nonpathogenic PCV1 in weanling pigs.

Authors:  M Fenaux; T Opriessnig; P G Halbur; X J Meng
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Effect of porcine circovirus type 2 (PCV2) vaccination of the dam on PCV2 replication in utero.

Authors:  D M Madson; A R Patterson; S Ramamoorthy; N Pal; X J Meng; T Opriessnig
Journal:  Clin Vaccine Immunol       Date:  2009-04-08

10.  Porcine circovirus type 2 (PCV2)-infection and re-inoculation with homologous or heterologous strains: virological, serological, pathological and clinical effects in growing pigs.

Authors:  Tanja Opriessnig; John R Prickett; Darin M Madson; Hui-Gang Shen; Nicole M Juhan; Roman R Pogranichniy; Xiang-Jin Meng; Patrick G Halbur
Journal:  Vet Res       Date:  2010-01-18       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.